Literature DB >> 23883574

Real-time characterization of the molecular epidemiology of an influenza pandemic.

J Hedge1, S J Lycett, A Rambaut.   

Abstract

Early characterization of the epidemiology and evolution of a pandemic is essential for determining the most appropriate interventions. During the 2009 H1N1 influenza A pandemic, public databases facilitated widespread sharing of genetic sequence data from the outset. We use Bayesian phylogenetics to simulate real-time estimates of the evolutionary rate, date of emergence and intrinsic growth rate (r0) of the pandemic from whole-genome sequences. We investigate the effects of temporal range of sampling and dataset size on the precision and accuracy of parameter estimation. Parameters can be accurately estimated as early as two months after the first reported case, from 100 genomes and the choice of growth model is important for accurate estimation of r0. This demonstrates the utility of simple coalescent models to rapidly inform intervention strategies during a pandemic.

Entities:  

Keywords:  Bayesian phylogenetics; influenza; pandemic; parameter estimation; real-time

Mesh:

Year:  2013        PMID: 23883574      PMCID: PMC3971669          DOI: 10.1098/rsbl.2013.0331

Source DB:  PubMed          Journal:  Biol Lett        ISSN: 1744-9561            Impact factor:   3.703


Introduction

When the swine-origin influenza A virus (A(H1N1)pdm09) was detected in April 2009, rapid characterization of its transmission potential and pathogenicity was urgently required for determination of appropriate interventions [1]. Early estimates of its emergence and transmission using phylogenetic analysis of genetic sequence data were reported within just three months of detection [2,3]. Such analyses are possible owing to rapid accumulation of genetic variation within the virus population, enabling its evolution to be modelled on an epidemiological timescale [4]. Here, we determine the efficiency with which Bayesian phylogenetics based on coalescent processes can estimate the evolutionary rate, date of emergence and intrinsic growth rate, r0, of A(H1N1)pdm09 using whole-genomes. The evolutionary rate provides an indication of the adaptive potential of a virus in a new host population. Accurate estimation is required for inferring divergence times and population size changes. The time of the most recent common ancestor (TMRCA) of a random sample of viruses provides an upper bound to the date of emergence of an epidemic. We use simple parametric growth models to estimate r0 as a measure of the relative ease with which A(H1N1)pdm09 spread through a host population.

Material and methods

We downloaded all available A(H1N1)pdm09 whole-genome sequences sampled April–December 2009 from the EpiFlu database hosted by the Global Initiative on Sharing All Influenza Data (GISAID; platform.gisaid.org) on 26 April 2010 (see the electronic supplementary material, table S1). We analysed whole-genomes (by concatenating segments) to maximize genetic variation in the dataset and only included North American samples to limit spatial heterogeneity in viral population structure. We removed all isolates sampled from a non-human host, missing an exact sampling date, or with sequencing coverage less than 80% for any genome segment. To minimize the effect of epidemiologically linked cases, which may confound assumptions of the coalescent, we subsampled one isolate/location/day [5,6], resulting in a dataset of 328 sequences. After aligning, we trimmed sequences to 13 158 bp. We carried out Bayesian phylogenetic analysis of the entire dataset in BEAST v. 1.7.4 [7-9], using the GTR+Γ nucleotide substitution model and uncorrelated lognormal relaxed molecular clock, which had greater Bayes factor support than a strict clock (BF = 3.65) [10,11]. The clock used a gamma-distributed prior on the mean evolutionary rate, with a mean of 1 substitution/site/year (k = 0.001, θ = 1000) and exponentially distributed prior on the standard deviation (μ = 0.333). To model the demographic history of the virus population, we used the non-parametric Gaussian Markov random fields Bayesian skyride model [12], which specifies the prior on the TMRCA. We performed four independent Markov chain Monte Carlo runs of 100 million steps to achieve good mixing, sampling trees every 10 000 steps and combining runs after removing 10% burn-in. To investigate how accurately and precisely Bayesian phylogenetics can estimate the evolutionary rate, date of emergence and r0 throughout the pandemic, we extracted nine subsets of sequences, each with an increasingly longer temporal range and size. This sampling strategy is akin to carrying out phylogenetic analyses using all genome data available at the end of each month between April and December 2009. Given the increasing capacity with which sequencing can be performed, we included all data available from GISAID on 26 April 2010 to estimate parameters from the maximum amount of sequence data that could have potentially been available if samples were sequenced immediately. We used the same evolutionary models as above but replaced the skyride model with either an exponential or logistic growth model [13]. Here, we use the TMRCA to represent the date of emergence of the virus into the larger human population, assuming a single initial case. We quantified the relative fit of both growth models by comparing their marginal likelihoods as Bayes factors. The marginal-likelihood measures the average fit of a model to the data and we estimated this using a recently described path sampling procedure [11].

Results

The skyride plot in figure 1 shows that the reconstructed past population dynamics of A(H1N1)pdm09 closely follows the number of newly confirmed A(H1N1)pdm09 cases per week (accessed via FluNet; http://who.int/influenza/gisrs_laboratory/flunet/), used here as a measure of incidence rate. This plot captures the exponential growth phase of the first pandemic wave, the plateau in genetic diversity and the growth phase during the second pandemic wave.
Figure 1.

Bayesian skyride reconstruction of the demographic history of A(H1N1)pdm09 in North America until December 2009. Mean genetic diversity (solid black) with corresponding 95% BCI (grey) are shown in (a–c). Incidence rate (number of new A(H1N1)pdm09 cases confirmed by the WHO/week; dashed) is plotted on secondary axes in (a). Similar reconstructions from analysis of the nine cumulative datasets under the (b) exponential and (c) logistic growth models are plotted with saturation increasing with dataset size in each analysis.

Bayesian skyride reconstruction of the demographic history of A(H1N1)pdm09 in North America until December 2009. Mean genetic diversity (solid black) with corresponding 95% BCI (grey) are shown in (a–c). Incidence rate (number of new A(H1N1)pdm09 cases confirmed by the WHO/week; dashed) is plotted on secondary axes in (a). Similar reconstructions from analysis of the nine cumulative datasets under the (b) exponential and (c) logistic growth models are plotted with saturation increasing with dataset size in each analysis. The evolutionary rate and date of emergence estimated from the first 34 sampled genomes have wide 95% Bayesian credible intervals (BCI) under both growth models, representing high uncertainty associated with the small sample size (figure 2). Precision increases when the dataset size is increased threefold with the addition of sequences sampled during May, from which the date of emergence is estimated to be 2 February 2009 (95% BCI: 12 January 2009, 2 March 2009) and evolutionary rate 3.93 × 103 substitutions/site/year (95% BCI: 2.99, 5.53 × 103) with a standard deviation of 0.24 (95% BCI: 8.9 × 106, 4.5 × 10−1) under the exponential growth model. The date of emergence remains roughly consistent at later time-points and any further increase in precision is limited by the lack of alternative independent loci. Conversely, the mean evolutionary rate estimates tend to decrease with the addition of data over time, suggesting that many early deleterious/neutral mutations may have later been purged from the population through purifying selection [3,5,14].
Figure 2.

(a) Mean evolutionary rate, (b) date of emergence and (c) r0 estimates from Bayesian phylogenetic analysis of A(H1N1)pdm09 whole-genomes sampled cumulatively at the end of every month between April and December 2009 across North America. Exponential (red) and logistic (blue) growth models were used in analyses of each dataset. Error bars represent 95% BCI. Dataset size is displayed underneath month names in brackets.

(a) Mean evolutionary rate, (b) date of emergence and (c) r0 estimates from Bayesian phylogenetic analysis of A(H1N1)pdm09 whole-genomes sampled cumulatively at the end of every month between April and December 2009 across North America. Exponential (red) and logistic (blue) growth models were used in analyses of each dataset. Error bars represent 95% BCI. Dataset size is displayed underneath month names in brackets. In contrast to either of the other parameters, the choice of growth model has a considerable effect on r0 estimation (figure 2). By the end of April, both growth models fail to estimate r0 with sufficient precision to discriminate between slow and rapid epidemic growth because of the small number of sequences sampled. However, uncertainty rapidly reduces by approximately 50% under the exponential growth model with the addition of 66 sequences in May. In comparison, precision remains low during the first three months under the logistic growth model, representing over-parametrization of the model with smaller datasets. The exponential growth model consistently estimates r0 with greater precision than the logistic model early in the pandemic, once data sampled after May are included in the analysis. Genetic diversity plateaus around June and the exponential growth model inappropriately adjusts for this by lowering the r0 estimate (figure 1b). As the logistic growth model accommodates for this plateau, the accuracy of r0 estimates remains largely unaffected by the inclusion of data from the second wave (figure 1c). A Bayes factor test favours the exponential over the logistic model until June, when support switches and increases as data sampled throughout the following months are included in the analysis (table 1).
Table 1.

Log-marginal likelihoods of both growth models used to analyse the nine subsets of sequences with increasing temporal ranges. The preferred model for each dataset (values in italics) was determined using a Bayes factor test, in which the exponential growth model was the null model.

last month sampled in datasetno. sequences in datasetlog-marginal likelihood
Bayes factor
exponential growth modellogistic growth model
April 3419697.73−19698.77−1.03
May10022630.98−22633.16−2.18
June164−26029.9026029.200.70
July186−27662.7927650.5412.25
August206−29552.0129543.428.59
September243−33031.0633009.2321.83
October276−36103.4636078.9124.55
November307−39147.3239115.7231.60
December328−41934.9641912.8722.09
Log-marginal likelihoods of both growth models used to analyse the nine subsets of sequences with increasing temporal ranges. The preferred model for each dataset (values in italics) was determined using a Bayes factor test, in which the exponential growth model was the null model. Here, r0 can be used to estimate the basic reproductive ratio (R0), which describes the average number of secondary infections arising from a primary infection [15]. For example, assuming a gamma-distributed generation time [16,17] with μ = 2.6 and σ = 1.3 (estimates from household data in the USA [18]), and r0 estimated from the first two months of data (100 sequences) under an exponential growth model, we estimate an R0 of 1.12 (95% BCI: 1.07, 1.16). This supports previous estimates from phylogenetic analyses of A(H1N1)pdm09 but is towards the lower end of estimates from incidence data sampled over similar temporal and spatial scales [2,19,20]. We investigated the effect of sample size on parameter estimation by constraining each cumulative dataset to 100 randomly selected genomes (see electronic supplementary material, figure S1). Although variation exists between the means of estimates from different random subsamples at each time-point, their 95% BCIs overlap with one another and those from analysis of the complete dataset. Additionally, the complete dataset provides only slightly higher precision of estimates of each parameter.

Discussion

Widespread genome sequencing and rapid sharing of data during the 2009 H1N1 pandemic enabled real-time characterization of an influenza pandemic for the first time [2,3,5]. Within approximately two months of the first cases (100 genomes), estimates of evolutionary rate, date of emergence and r0 from sequence data were in agreement with those from analyses of incidence data, where comparison is available [1,2,19,20]. Over a longer sampling period, parameter estimates from 100 genomes maintain similar accuracy and precision to estimates from more intensively sampled datasets. We discuss potential reasons for the general decrease in evolutionary rate observed over time, although the difference in evolutionary rates is not significant and the datasets are not independent so this result should be interpreted with caution. The exponential growth model accurately estimates all three parameters during the exponential growth phase, although precision was low with less than 100 sequences. Once growth begins to plateau, this model should be replaced by the logistic growth model to avoid severely underestimating r0. A demographic reconstruction using a non-parametric coalescent model, such as the skyline or skyride model, can be used to reveal when exponential growth ceases [12,21]. However, these models are unable to estimate the change in relative genetic diversity between the most recent coalescent event and the youngest sample. If this time is large, the demographic plot may appear to flatten prematurely [6]. The exponential growth model is unaffected by an absence of recent coalescence events, estimating r0 from the density of early coalescent events. Simple parametric coalescent models are powerful tools for early characterization of an epidemic, even while growth remains exponential. More complex phylogenetic models have been developed to estimate epidemiological parameters that cannot be achieved with parametric coalescent models alone [22-25]. However, the over-parametrization of early A(H1N1)pdm09 data under the logistic growth model highlights the disadvantages of using highly parametrized models during the initial stages of an epidemic. With the increasing capacity of sequencing technologies, the lag between sampling and sequencing viral genomes is expected to decrease, making earlier parameter estimation feasible in future epidemics and before alternative types of data become available.
  24 in total

1.  Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution.

Authors:  Oliver G Pybus; Andrew Rambaut; Robert Belshaw; Robert P Freckleton; Alexei J Drummond; Edward C Holmes
Journal:  Mol Biol Evol       Date:  2007-01-11       Impact factor: 16.240

2.  How generation intervals shape the relationship between growth rates and reproductive numbers.

Authors:  J Wallinga; M Lipsitch
Journal:  Proc Biol Sci       Date:  2007-02-22       Impact factor: 5.349

3.  Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics.

Authors:  Vladimir N Minin; Erik W Bloomquist; Marc A Suchard
Journal:  Mol Biol Evol       Date:  2008-04-11       Impact factor: 16.240

4.  Sampling theory for neutral alleles in a varying environment.

Authors:  R C Griffiths; S Tavaré
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-06-29       Impact factor: 6.237

5.  Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

Authors:  Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman
Journal:  CMAJ       Date:  2009-12-03       Impact factor: 8.262

6.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

7.  Phylodynamics of infectious disease epidemics.

Authors:  Erik M Volz; Sergei L Kosakovsky Pond; Melissa J Ward; Andrew J Leigh Brown; Simon D W Frost
Journal:  Genetics       Date:  2009-09-21       Impact factor: 4.562

8.  Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty.

Authors:  Guy Baele; Philippe Lemey; Trevor Bedford; Andrew Rambaut; Marc A Suchard; Alexander V Alekseyenko
Journal:  Mol Biol Evol       Date:  2012-03-07       Impact factor: 16.240

9.  Bayesian phylogenetics with BEAUti and the BEAST 1.7.

Authors:  Alexei J Drummond; Marc A Suchard; Dong Xie; Andrew Rambaut
Journal:  Mol Biol Evol       Date:  2012-02-25       Impact factor: 16.240

Review 10.  Unifying the epidemiological and evolutionary dynamics of pathogens.

Authors:  Bryan T Grenfell; Oliver G Pybus; Julia R Gog; James L N Wood; Janet M Daly; Jenny A Mumford; Edward C Holmes
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

View more
  19 in total

Review 1.  Infectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential.

Authors:  Manoj Gambhir; Catherine Bozio; Justin J O'Hagan; Amra Uzicanin; Lucinda E Johnson; Matthew Biggerstaff; David L Swerdlow
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

2.  Phylodynamic Model Adequacy Using Posterior Predictive Simulations.

Authors:  Sebastian Duchene; Remco Bouckaert; David A Duchene; Tanja Stadler; Alexei J Drummond
Journal:  Syst Biol       Date:  2019-03-01       Impact factor: 15.683

Review 3.  Emerging Concepts of Data Integration in Pathogen Phylodynamics.

Authors:  Guy Baele; Marc A Suchard; Andrew Rambaut; Philippe Lemey
Journal:  Syst Biol       Date:  2017-01-01       Impact factor: 15.683

4.  Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics.

Authors:  Venkata R Duvvuri; Andrea Granados; Paul Rosenfeld; Justin Bahl; Alireza Eshaghi; Jonathan B Gubbay
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

Review 5.  Genomic analysis of emerging pathogens: methods, application and future trends.

Authors:  Lucy M Li; Nicholas C Grassly; Christophe Fraser
Journal:  Genome Biol       Date:  2014-11-22       Impact factor: 13.583

6.  Fast Dating Using Least-Squares Criteria and Algorithms.

Authors:  Thu-Hien To; Matthieu Jung; Samantha Lycett; Olivier Gascuel
Journal:  Syst Biol       Date:  2015-09-30       Impact factor: 15.683

7.  Phylogenetic Exploration of Nosocomial Transmission Chains of 2009 Influenza A/H1N1 among Children Admitted at Red Cross War Memorial Children's Hospital, Cape Town, South Africa in 2011.

Authors:  Ziyaad Valley-Omar; Fredrick Nindo; Maanda Mudau; Marvin Hsiao; Darren Patrick Martin
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

8.  Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent Epidemics in Coastal Kenya.

Authors:  James R Otieno; Charles N Agoti; Caroline W Gitahi; Ann Bett; Mwanajuma Ngama; Graham F Medley; Patricia A Cane; D James Nokes
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

9.  Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection.

Authors:  Yvonne C F Su; Justin Bahl; Udayan Joseph; Ka Man Butt; Heidi A Peck; Evelyn S C Koay; Lynette L E Oon; Ian G Barr; Dhanasekaran Vijaykrishna; Gavin J D Smith
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

Review 10.  Virus evolution and transmission in an ever more connected world.

Authors:  Oliver G Pybus; Andrew J Tatem; Philippe Lemey
Journal:  Proc Biol Sci       Date:  2015-12-22       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.